ENDP : Analysis & Opinions

  1. Two Biotechs Worth A Look Ahead Of FDA Approvals

    September 8, 2015
    Analysts sit patiently as BioDelivery Sciences and Spectrum Pharma await FDA approvals on pipeline drugs.
  2. Analysts Bullish on BioDelivery Ahead of FDA Event

    August 18, 2015
    Analysts expect BioDelivery stock to be bolstered by the upcoming PDUFA date and potential FDA approval for BELBUCA on October ...
  3. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  4. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  5. The Salix Story Keeps Improving

    January 18, 2012
    Salix is a great candidate for growth investors.
  6. Endo And Forest – Dumpster-Diving In Pharma

    September 21, 2011
    Endo and Forest have problems; however, the valuations seem excessively low.
Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!